Drugs / carbo
last change Jul 2024 re-read 3 minutes ago

carbo

Developed for
non-small cell lung carcinoma
Investigated by
Bristol-Myers Squibb · Ralph G Zinner

Trials 1

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06003075 Dec 2023 → Jul 2024 non-small cell lung carcinoma Ralph G Zinner Terminated No outcome recorded Stop: Enrollment

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as carbo “pemetrexed + carbo/cis or paclitaxel + carbo or docetaxel + carbo/cis for non squamous” NCT06003075 ↗